Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.


Journal

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
ISSN: 2008-2231
Titre abrégé: Daru
Pays: Switzerland
ID NLM: 101125969

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 01 05 2019
accepted: 16 01 2020
pubmed: 2 2 2020
medline: 27 2 2021
entrez: 2 2 2020
Statut: ppublish

Résumé

Rod-like mesoporous silica nanoparticles with pH-responsive amphiphilic hyperbranched polyester shells were prepared for doxorubicin (DOX) delivery. First, rod-shaped mesoporous silica nanoparticles (MSNs) were obtained, then hydrophobic hyperbranched polyester Boltorn H40 (H40) was grafted on their surface. The H40 coated MSNs were next treated with amine-functionalized polyethylene glycol (PEG) to achieve the hydrophilic and pH-responsive material denoted as PEG-H40-MSNs. The experimental results showed that PEG-H40-MSNs were successfully synthesized. BET analysis showed that rod MSNs exhibits a type IV standard isotherm. TEM revealed that the thin gray polymer layer was formed around the SBA-15 particle with a diameter of around 150 nm. DOX was effectively loaded, which can be released according to the ambient pH inside the cell as follow: at pH 7.4, only 9.7% of the DOX was released after 48 h; as the pH decreased to 5.5, the cumulative release reached to 49% at the same time. PEG-H40-MSNs showed less than 1.6% of hemolytic activity and a slight effect on the liver and kidney of treated mice were observed at a high disposal dosage implying negligible toxicities were caused by PEG-H40-MSNs in both in vitro hemolysis analysis and in vivo biochemical in mice. However, the in vitro cytotoxicity evaluation of the DOX-PEG-H40-MSNs showed that the cell cytotoxicity of both pure DOX and DOX-loaded PEG-H40-MSNs generally enhanced by increasing the concentration of DOX. Graphical abstract Schematic of cellular uptake and DOX release of PEG-H40-MSNs nanoparticle.

Identifiants

pubmed: 32006342
doi: 10.1007/s40199-020-00328-x
pii: 10.1007/s40199-020-00328-x
pmc: PMC7214578
doi:

Substances chimiques

Antibiotics, Antineoplastic 0
Drug Carriers 0
SBA-15 0
Polyethylene Glycols 3WJQ0SDW1A
Silicon Dioxide 7631-86-9
Doxorubicin 80168379AG

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-180

Références

Daru. 2017 Sep 4;25(1):20
pubmed: 28870261
J Mater Chem B. 2014 Jan 21;2(3):253-256
pubmed: 32261504
Daru. 2012 Oct 25;20(1):67
pubmed: 23351403
Polymers (Basel). 2018 Apr 14;10(4):
pubmed: 30966478
J Colloid Interface Sci. 2018 Feb 15;512:134-140
pubmed: 29055795
J Mater Chem B. 2017 Feb 21;5(7):1339-1352
pubmed: 32264626
Eur J Pharm Biopharm. 2012 Feb;80(2):247-56
pubmed: 22085653
Int J Pharm. 2017 May 15;523(1):217-228
pubmed: 28330734
Acta Biomater. 2017 Feb;49:531-540
pubmed: 27836804
Daru. 2015 Aug 19;23:41
pubmed: 26283081
Daru. 2013 Jan 05;21(1):3
pubmed: 23351402
ACS Nano. 2011 Jul 26;5(7):5717-28
pubmed: 21630682
J Nanosci Nanotechnol. 2016 Jan;16(1):40-57
pubmed: 27398432
Ultrason Sonochem. 2017 Nov;39:144-152
pubmed: 28732931
Soft Matter. 2018 Oct 17;14(40):8090-8094
pubmed: 30283943
Mater Sci Eng C Mater Biol Appl. 2018 Jan 1;82:1-9
pubmed: 29025636
Biomaterials. 2009 Oct;30(29):5815-24
pubmed: 19615740

Auteurs

Reza Bafkary (R)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Shirin Ahmadi (S)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Faeze Fayazi (F)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Mehdi Karimi (M)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Yousef Fatahi (Y)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Seyed Mostafa Ebrahimi (SM)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Fatemeh Atyabi (F)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Rassoul Dinarvand (R)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. dinarvand@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH